he management of Graves disease (GD) requires integrated participation from multiple disciplines to provide optimal care for patients. Being familiar with the treatment options and their indications will help clinicians ensure optimal care for their patients, which may have positive consequences for quality of life.The incidence of pediatric GD is thought to be rising and varies widely. Prevalence rates have geographic variance worldwide, ranging from 1 case per 10 000 in the US to 1 case per 100 000 in the UK and Ireland and as many as 14 cases per 100 000 in Hong Kong. [1][2][3] Graves disease accounts for 10% to 15% of thyroid disorders during childhood and is much more frequent in female than in male patients. 1,4 This review focuses on the diagnosis and management of GD specifically in children. The evaluation of these patients includes biochemical tests and, possibly, imaging; it is important to know how to interpret these test results and how confident one can be in a diagnosis. The management options-specifically medical therapy, nuclear medicine therapy with radioactive iodine (RAI), or surgical therapy-will be discussed in detail, with a special focus on indications, contraindications, and adverse effects or complications of each modality.
MethodsThe purpose of this review is to present a broad perspective on pediatric GD. The authors span a variety of disciplines relevant to the subject of pediatric GD, including otolaryngology-head and neck surgery, pediatric endocrinology, radiology with a focus on nuclear medicine, and ophthalmology. We conducted an extensive literature review and obtained expert opinion where appropriate. We also performed a PubMed literature search to identify the most up-todate and relevant information on the subject using the search terms Graves disease, hyperthyroidism, pediatric, Graves orbitopathy, methimazole, antithyroid drugs, radioactive iodine, and thyroidectomy, individually or in combination.
Results
DefinitionsThyrotoxicosis is defined by the 2016 American Thyroid Association's (ATA) guidelines as "a clinical state that results from inappro-IMPORTANCE The incidence of Graves disease (GD) is rising in children, and adequate care of these patients requires a multidisciplinary approach. Whether patients are seen in the context of endocrinology, nuclear medicine, or surgery, it is important to know the nuances of the therapeutic options in children.OBSERVATIONS Given the rarity of GD in children, it is important to recognize its various clinical presenting signs and symptoms, as well as the tests that may be important for diagnosis. The diagnosis is typically suspected clinically and then confirmed biochemically. Imaging tests, including thyroid ultrasonography and/or nuclear scintigraphy, may also be used as indicated during care. It is important to understand the indications for and interpretation of laboratory and imaging tools so that a diagnosis is made efficiently and unnecessary tests are not ordered. Clinicians should be well-versed in treatment options to appro...